Jun 25, 2026
15 MIN READ

Wegovy Starting Dose: What You Need to Know for Your Weight Loss Journey

Semaglutide therapy begins with a low starting dose that increases gradually over weeks. PlexusDx uses genetic insights to personalize your initial dose and trajectory, ensuring safety while maximizing your weight loss potential.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 25, 2026
15 MIN READ

wegovy starting dose: what you need to know for your weight loss journey — PlexusDx GLP-1 education

Last reviewed: June 25, 2026

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Starting semaglutide for weight loss requires careful dose titration to minimize side effects while building tolerance. Research shows that gradual dose escalation over 16 weeks produces the best outcomes, with participants losing an average of 15% of body weight when combined with lifestyle changes. PlexusDx tailors your starting point based on your genetic profile and health history, not a one-size-fits-all approach.

Why Semaglutide Requires a Gradual Starting Dose

Semaglutide works by activating GLP-1 receptors in your brain and gut, signaling fullness and slowing stomach emptying. A high initial dose would overwhelm your system, triggering intense nausea, vomiting, and appetite suppression that many patients cannot tolerate. Starting low—typically 0.25 mg once weekly—allows your body to adapt to these powerful signals while your appetite naturally decreases.

Clinical trials demonstrate that slow titration reduces dropout rates due to side effects by up to 40% compared to faster protocols. Your tolerance improves week by week as your GLP-1 receptors become more responsive. This gradual approach isn't a limitation—it's the evidence-based path to sustainable, long-term weight loss without unnecessary suffering.

Understanding the Standard Semaglutide Dose Escalation Schedule

The typical semaglutide titration follows a 4-week step pattern: Week 1-4 uses 0.25 mg weekly, Week 5-8 increases to 0.5 mg weekly, Week 9-12 moves to 1.0 mg weekly, and Week 13+ reaches the maintenance dose of 2.4 mg weekly. Each step gives your body time to adjust while your provider monitors tolerability and weight loss progress. Some patients reach their goal weight before reaching 2.4 mg and may remain on a lower maintenance dose indefinitely.

Your individual starting dose may differ based on factors like kidney function, prior GLP-1 exposure, and genetic variants affecting peptide metabolism. PlexusDx evaluates these variables before your first injection, potentially adjusting the standard schedule to match your physiology. This personalized approach reduces the trial-and-error period that delays results.

How PlexusDx Personalizes Your Semaglutide Starting Protocol

PlexusDx offers the Precision Peptide Genetic Test, which analyzes key variants in your GLP1R, GIPR, FTO, and MC4R genes—four critical pathways controlling appetite and metabolic rate. Your results map 14 distinct peptide pathways and 150+ genetic insights that predict how strongly you'll respond to semaglutide and whether you're a fast or slow responder. A patient with a favorable GLP1R variant may begin titration confidently, while someone with reduced receptor sensitivity might benefit from a slightly extended timeline.

Beyond genetics, PlexusDx considers your medical history, current medications, and weight loss goals when recommending your starting dose. The Precision Peptide Test is a $99 add-on available after your first month of treatment, allowing your provider to refine your dose trajectory based on real data rather than assumptions. This genetic foundation transforms semaglutide from a generic treatment into a precision therapy designed for your unique biology.

What to Expect During Your First Weeks of Semaglutide Treatment

Most patients notice appetite suppression within 3-5 days of their first 0.25 mg injection, though the effect is mild compared to higher doses. You may experience mild nausea, constipation, or fatigue during the first week—normal symptoms that typically fade by day 7 as your body acclimates. Many patients report reduced cravings, smaller portion sizes feeling satisfying, and less frequent snacking without actively restricting food.

Weight loss in the first month averages 2-4 pounds, which accelerates as your dose increases. PlexusDx recommends tracking side effects in a simple journal and reporting them during your follow-up visits at weeks 2, 4, and 8. If side effects become intolerable, your provider can extend the time at each dose level or adjust your eating patterns (smaller, less fatty meals) to improve comfort while maintaining progress.

Semaglutide Pricing and Access at PlexusDx

PlexusDx offers Compounded Semaglutide Injection starting at $149 per month, with all medications sourced from licensed 503A compounding pharmacies. No insurance is required, no membership fees apply, and HSA/FSA accounts are accepted—making precision GLP-1 therapy accessible whether your plan covers it or not. Your dose may need to go up. Your price won't. This means you pay the same monthly rate whether you're on 0.25 mg or 2.4 mg.

PlexusDx serves all 50 states and ships directly to your home with no prior authorization delays. Your initial virtual consultation includes a medical assessment, medication selection (semaglutide, tirzepatide, or dual-compound options), and dose recommendations. Add the Precision Peptide Genetic Test in month two to unlock personalized pathway insights that optimize your long-term protocol and help you avoid ineffective dosing.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is 0.25 mg actually an effective starting dose for weight loss?

Yes—0.25 mg is clinically effective at initiating appetite suppression and building tolerance. It's not meant to produce maximal weight loss; rather, it primes your GLP-1 receptors so higher doses work better when you advance. Most weight loss accelerates at 1.0 mg and beyond, but starting low prevents dropout and side effects that derail long-term success.

What does clinical evidence say about semaglutide's weight loss timeline?

The STEP trials showed participants lost 15-18% of body weight over 68 weeks on semaglutide 2.4 mg combined with lifestyle changes. Week 4-12 typically yields 5-8 pounds, while weeks 13-24 accelerate to 10-15 additional pounds. Maximum benefit appears around 16-20 weeks, with weight loss continuing through month 12 but at a slower rate.

Does PlexusDx charge extra if my dose increases from 0.25 mg to 2.4 mg?

No. PlexusDx Compounded Semaglutide Injection costs $149 per month regardless of your dose level. You pay one flat monthly rate whether you're starting or fully titrated. This pricing model ensures you're never penalized for achieving your target dose.

What if I experience severe nausea on the starting dose?

Mild nausea in week 1 is common and usually resolves by day 7. If nausea persists or is severe, contact your PlexusDx provider immediately—they may extend your time at 0.25 mg, recommend smaller or less fatty meals, or adjust your injection timing. Tolerability modifications are far better than stopping treatment altogether.

How does the Precision Peptide Genetic Test change my starting dose?

The test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that predict your response intensity and metabolism speed. If you carry favorable variants, your provider may feel confident advancing your dose on schedule. Unfavorable variants might suggest a slower titration or higher maintenance dose. Testing costs $99 and is available after your first treatment month.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves